Shares of healthcare professional network Doximity (NYSE:DOCS)
fell 11.7% in the afternoon session after the company reported weak first quarter 2025 results: its revenue guidance for next year fell short of Wall Street's estimates and suggested a significant slowdown in demand. Notably, top-line growth decelerated significantly, up 17% (versus 25% growth in the previous quarter).
As we await the opening of the US market on Friday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
DOXIMITY INC (NYSE:DOCS) is an affordable growth stock with strong profitability, zero debt, and solid earnings growth, trading at a reasonable valuation relative to peers.
The company reported a strong Q4 with 17% revenue growth but saw shares drop 20% after hours following conservative FY26 revenue and Q1 guidance that missed analyst estimates.
Healthcare professional network Doximity (NYSE:DOCS) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 17.1% year on year to $138.3 million. On the other hand, next quarter’s revenue guidance of $139.5 million was less impressive, coming in 2.4% below analysts’ estimates. Its non-GAAP profit of $0.38 per share was 39.3% above analysts’ consensus estimates.
After the conclusion of the US market's regular session on Thursday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Doximity has been treading water for the past six months, holding steady at $58. However, the stock is beating the S&P 500’s 6.2% decline during that period.
